CFB
EW icon

Cullen/Frost Bankers’s Edwards Lifesciences EW Stock Holding History

Cullen/Frost Bankers’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$944K Sell
11,789
-2,961
-20% -$244K 0.01% 345
2025
Q4 		$1.26M Sell
14,750
-204
-1% -$16.7K 0.01% 322
2025
Q3 		$1.16M Sell
14,954
-278
-2% -$21.7K 0.01% 315
2025
Q2 		$1.19M Sell
15,232
-1,970
-11% -$147K 0.01% 302
2025
Q1 		$1.25M Sell
17,202
-836
-5% -$59.8K 0.02% 291
2024
Q4 		$1.34M Sell
18,038
-195
-1% -$13.6K 0.02% 279
2024
Q3 		$1.2M Sell
18,233
-24,037
-57% -$1.75M 0.02% 283
2024
Q2 		$3.9M Sell
42,270
-127,534
-75% -$11.3M 0.06% 207
2024
Q1 		$16.2M Sell
169,804
-7,703
-4% -$647K 0.24% 100
2023
Q4 		$13.5M Sell
177,507
-7,313
-4% -$509K 0.21% 118
2023
Q3 		$12.8M Sell
184,820
-4,255
-2% -$342K 0.22% 110
2023
Q2 		$17.8M Buy
189,075
+14,015
+8% +$1.22M 0.3% 86
2023
Q1 		$14.5M Sell
175,060
-23,450
-12% -$1.84M 0.26% 103
2022
Q4 		$14.8M Buy
198,510
+40,772
+26% +$3.14M 0.28% 101
2022
Q3 		$13M Buy
157,738
+5,050
+3% +$486K 0.3% 87
2022
Q2 		$14.5M Sell
152,688
-776
-0.5% -$80.3K 0.33% 87
2022
Q1 		$18.1M Buy
153,464
+892
+0.6% +$100K 0.35% 78
2021
Q4 		$19.8M Sell
152,572
-5,088
-3% -$593K 0.38% 70
2021
Q3 		$17.8M Sell
157,660
-7,305
-4% -$834K 0.36% 75
2021
Q2 		$17.1M Sell
164,965
-15,776
-9% -$1.49M 0.34% 79
2021
Q1 		$15.1M Sell
180,741
-3,007
-2% -$254K 0.33% 85
2020
Q4 		$16.8M Sell
183,748
-5,864
-3% -$486K 0.39% 74
2020
Q3 		$15.1M Sell
189,612
-13,659
-7% -$1.07M 0.38% 73
2020
Q2 		$14M Sell
203,271
-7,494
-4% -$533K 0.37% 73
2020
Q1 		$13.3M Sell
210,765
-4,284
-2% -$309K 0.46% 61
2019
Q4 		$16.7M Sell
215,049
-3,096
-1% -$242K 0.46% 68
2019
Q3 		$16M Sell
218,145
-8,280
-4% -$582K 0.47% 66
2019
Q2 		$13.9M Sell
226,425
-822
-0.4% -$49.7K 0.43% 72
2019
Q1 		$14.5M Sell
227,247
-7,386
-3% -$422K 0.45% 79
2018
Q4 		$12M Sell
234,633
-186,093
-44% -$9.42M 0.45% 72
2018
Q3 		$24.4M Sell
420,726
-59,460
-12% -$2.91M 0.76% 35
2018
Q2 		$23.3M Sell
480,186
-48,966
-9% -$2.29M 0.72% 40
2018
Q1 		$24.6M Buy
529,152
+128,970
+32% +$5.6M 0.72% 43
2017
Q4 		$15M Buy
400,182
+21,798
+6% +$800K 0.48% 78
2017
Q3 		$13.8M Buy
378,384
+2,145
+0.6% +$81.8K 0.45% 79
2017
Q2 		$14.8M Buy
376,239
+34,224
+10% +$1.25M 0.5% 78
2017
Q1 		$10.7M Buy
342,015
+31,812
+10% +$996K 0.37% 94
2016
Q4 		$9.69M Buy
+310,203
New +$10.1M 0.33% 101
2013
Q4 		– Sell
-817,962
Closed -$9.49M – 374
2013
Q3 		$9.49M Buy
817,962
+312,750
+62% +$3.66M 0.47% 73
2013
Q2 		$5.66M Buy
+505,212
New +$5.98M 0.3% 109

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Cullen/Frost Bankers's EW Position: Q1 2026 in Review

Cullen/Frost Bankers reduced its Edwards Lifesciences (EW) stake by 20% in Q1 2026, selling an estimated $244K and leaving 11,789 shares worth $944K. The position accounts for 0.01% of the portfolio, ranked #345.

Cullen/Frost Bankers first reported a position in EW in Q2 2013 and has held it in 40 quarters since. The position peaked at $24.6M in Q1 2018. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Cullen/Frost Bankers held 11,789 shares of Edwards Lifesciences worth $944K as of Q1 2026.
  • Cullen/Frost Bankers sold 2,961 Edwards Lifesciences shares in Q1 2026, an estimated $244K.
  • Edwards Lifesciences made up 0.01% of Cullen/Frost Bankers's portfolio in Q1 2026, its #345 holding.
  • Cullen/Frost Bankers first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 40 quarters since.
  • Cullen/Frost Bankers's Edwards Lifesciences position peaked at $24.6M in Q1 2018.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.